Are Concessions In FDA's Lab-Developed Tests Rule Enough?
On April 29, the U.S. Food and Drug Administration issued a highly anticipated — and highly controversial — final rule that rolls out a four-year, five-stage plan that will phase out...To view the full article, register now.
Already a subscriber? Click here to view full article